Evidence map›Paper›PMID 38937646›Full record

ArticleCommunications chemistry2024

Phage-encoded bismuth bicycles enable instant access to targeted bioactive peptides.

Sven Ullrich, Upamali Somathilake, Minghao Shang, Christoph Nitsche

Abstract read
In one paragraph

Article in Communications chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Bismuth Bicycles.Journal of peptide science : an official publication of the European Peptide Society · 2026
    Review
  8. Article
  9. Article
  10. De novo discovery of bicycles.Nature chemical biology · 2025
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sven Ullrich *Research School of Chemistry, Australian National University, Canberra, ACT 2601, Australia.ORCID http://orcid.org/0000-0003-4184-7024
Upamali Somathilake *Research School of Chemistry, Australian National University, Canberra, ACT 2601, Australia.ORCID http://orcid.org/0009-0007-7598-5675
Minghao ShangResearch School of Chemistry, Australian National University, Canberra, ACT 2601, Australia.ORCID http://orcid.org/0000-0003-4754-1245
Christoph NitscheResearch School of Chemistry, Australian National University, Canberra, ACT 2601, Australia. christoph.nitsche@anu.edu.au.ORCID http://orcid.org/0000-0002-3704-2699

Funding

Department of Education and Training | Australian Research Council (ARC) DP230100079Department of Education and Training | Australian Research Council (ARC) FT220100010
6 · The paper itself

Abstract

Genetically encoded libraries play a crucial role in discovering structurally rigid, high-affinity macrocyclic peptide ligands for therapeutic applications. Bicyclic peptides with metal centres like bismuth were recently developed as a new type of constrained peptide with notable affinity, stability and membrane permeability. This study represents the genetic encoding of peptide-bismuth and peptide-arsenic bicycles in phage display. We introduce bismuth tripotassium dicitrate (gastrodenol) as a water-soluble bismuth(III) reagent for phage library modification and in situ bicyclic peptide preparation, eliminating the need for organic co-solvents. Additionally, we explore arsenic(III) as an alternative thiophilic element that is used analogously to our previously introduced bicyclic peptides with a bismuth core. The modification of phage libraries and peptides with these elements is instantaneous and entirely biocompatible, offering an advantage over conventional alkylation-based methods. In a pilot display screening campaign aimed at identifying ligands for the biotin-binding protein streptavidin, we demonstrate the enrichment of bicyclic peptides with dissociation constants two orders of magnitude lower than those of their linear counterparts, underscoring the impact of structural constraint on binding affinity.

Identifiers

PMID38937646
PMCPMC11211329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.